United States · FDA National Drug Code directory
Pentoxifylline
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-856_465e591b-4af7-4b59-a076-73bc26758eda
- Product NDC
- 16571-856
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Pentoxifylline
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240611
- Source listing expiry
- 20271231
Source-listed ingredients
- PENTOXIFYLLINE — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-01) · 16571-856-01
- 50 BLISTER PACK in 1 CARTON (16571-856-05) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 16571-856-05
- 10 BLISTER PACK in 1 CARTON (16571-856-11) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 16571-856-11
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-50) · 16571-856-50
- 1 BLISTER PACK in 1 CARTON (16571-856-90) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 16571-856-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →